Copyright
©The Author(s) 2022.
World J Clin Cases. Feb 6, 2022; 10(4): 1296-1310
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1296
Published online Feb 6, 2022. doi: 10.12998/wjcc.v10.i4.1296
Ref. | Study design | Country | Sample size, n (%) | Age/sex (F:M) | COVID-19 diagnosis | Tokyo class | Treatment | Morbidity/PO complications | ICU, n (%) | LOS (d) | Mortality | Findings/histopathology |
Çakır and Kabuli[8], 2021 | Retrospective study | Turkey | 18 | M: 14 (78%); F: 4 (22%); Age: 73.3 (67-81) | RT-PCR | GI: 3 (16.7%); GII: 9 (50%); GIII: 6 (33.3%) | THGD | No complications | 3 (16.6%) | 16 (3-32) | 3 (16.6%) | NR |
Barabino et al[9], 2021 | Retrospective study | Italy | 37: 36 non-COVID; 1 COVID | 64 (38-94); Male: 21 (56.7%); Female 16 (43.3%) | RT-PCR | GI: 13 (35.1%); GII: 15 (40.5%); GIII: 8 (21.6%); COVID: GII | Antibiotic only 11 (29.7%); THGD 8 (21.6%); L 18 (48.7%); COVID: THGD 1 | Emergency LC 1; Bleeding 1; Cholangitis 2 | 2 | 9 (2-12) | - | - |
Martínez Caballero et al[10], 2021 | Multicentre-combined (retrospective–prospective) cohort study | Spain | 42 | Age: COVID: 83 (65-87); COVID: 28 M/14 F | Clinics 10.9%; Imaging test 11.3%; RT-PCR 12.5% | GI: 112 (43.6%); GII: 121 (47.1%); GIII: 24 (9.3%) | Antibiotic therapy 47.9%; Surgical treatment 31.5%; THGD 20.6%. COVID: 93.3% non surgical treatment | Gallblader perforation 8.4%; Biliar setic shock 8.4% | 23% | Non-COVID: 5 d (3–8). COVID: 11.0 d (7.5–27.5) | Non-COVID: 3.25%; COVID: 11.9% | - |
Çiyiltepe et al[11], 2021 | Retrospective study | Turkey | 65 non-COVID; 7 COVID | Age: 57.3; F: 40 (55.6)/M: 32 (44.4) | GI: 35 (48.6%); GII: 37 (51.3%) | 11 THGD | - | - | 9.2 (6-20) | - | - | |
Somuncu et al[12], 2021 | Retrospective study | Turkey | 4 COVID; 32 non-COVID | Age: 53 (26-78); M: 17/F: 19 | Thorax CT | - | Antibiotic therapy 14; THGD 14 (39%); LC 8 | - | - | 7 (2-20) | 1: Cardiac arrest | - |
Puig et al[13], 2021 | Case report | Spain | 2 | M: 65/57 | RT-PCR | GIII: 2 | Percutaneous cholecystostomy 2 | Pulmonary tromboemboly 2 | 2 | 34 | 0 | - |
Abaleka et al[14], 2021 | Case report | United States | 1 | Age: 76; F | RT-PCR | Grade II | Antibiotics | - | - | - | - | - |
Lovece et al[15], 2020 | Case report | Italy | 1 | Age: 42/M | RT-PCR | Grade III | LC | Gallblader perforation | - | - | - | - |
Famularo and Spada[16], 2021 | Letter/case report | Italy | 1 | 90/M | RT-PCR + | NR | THGD | No | No | 26 | No | NR |
Vaishnav and Patel[17], 2021 | Observational/prospective | India | 16 | 50/F: 7 (29%); M: 17 (70%) | RT-PCR + CT + | GIII | LC | No | NR | 4.9 | NR | NR |
Alhassan et al[18], 2020 | Case report | Qatar | 1 | 40/F | Confirmed 14 d prior | AAC | Antibiotics | No | Yes (1, 100%) | NR | No | - |
Asti et al[19], 2020 | Letter/case report | Italy | 3 | 40-86/F: 1 (33%); M: 2 (66%) | Confirmed | AAC | LC | NR | NR | NR | NR | Acalculous, gangrene |
Balaphas et al[20], 2020 | Letter/case report | Switzerland | 2 | 83-84/F: 1 (50%); M: 1 (50%) | RT-PCR + | AAC | LC/Antibiotics | NR | Yes (1, 50%) | NR | Yes (1, 50%) | qRT-PCR revealed the presence of SARS-CoV-2 in the gallbladder wall |
Bruni et al[21], 2020 | Case report | Italy | 1 | 59/M | RT-PCR + | AC/GIII | OC | NR | Yes (1, 100%) | 44 | No | Gangrenous, Hemorrhagic, vasculitis |
Cirillo et al[22], 2020 | Letter/case report | Italy | 1 | 79/M | Confirmed | AAC | Cholecystectomy | No | NR | NR | No | Perforated acalculous cholecystitis |
Giulio et al[23], 2020 | Letter/case report | Italy | 1 | 45/F | RT-PCR + | AC/GI | LC | No | NR | 30 | No | NR |
Gupta et al[24], 2020 | Retrospective original article | India | 5 | 53.2/NR | Confirmed | AC | OC | Bile leak | NR | 4-9 | No | Acute on chronic calculous cholecystitis, gangrenous acalculous cholecystitis |
Kabir et al[25], 2020 | Letter/case report | Singapore | 1 | Middle-aged/M | RT-PCR + | Gangrenous cholecystitis | Subtotal reconstituting OC | NR | NR | NR | NR | NR |
Lisotti et al[26], 2020 | Case report | Italy | 1 | 80/F | CT suspicious | AC/GII | EUS-GBD | No | No | 1 | NR | NR |
Mattone et al[27], 2020 | Case report | Italy | 1 | 66/M | RT-PCR + | AAC | Initially THGDLC | No | Yes | NR | No | Gangrenous gallbladder |
F Narvaez et al[28], 2020 | Brief report/review | United States | 1 | NR/F | Confirmed | AC | LC | No | No | NR | No | Near-gangrenous gallbladder |
Safari et al[29], 2020 | Case report | Iran | 1 | 75/F | RT-PCR +CT + | AC/GII | LC | NR | Yes (1, 100%) | 9 | Yes | NR |
Ying et al[30], 2020 | Case report | China | 1 | 68/F | RT-PCR + | AC/GII | THGD | No | No | 25 | No | NR |
- Citation: Bozada-Gutiérrez K, Trejo-Avila M, Chávez-Hernández F, Parraguirre-Martínez S, Valenzuela-Salazar C, Herrera-Esquivel J, Moreno-Portillo M. Surgical treatment of acute cholecystitis in patients with confirmed COVID-19: Ten case reports and review of literature. World J Clin Cases 2022; 10(4): 1296-1310
- URL: https://www.wjgnet.com/2307-8960/full/v10/i4/1296.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i4.1296